Diabetic Macular Edema

Lynda Charters Enoch started her early “eye life” at the Schepens Eye Research Institute, Boston, which ultimately culminated in her current position as an Editor of 

Articles

Metformin, a frequently prescribed drug to treat diabetes, could be a novel therapy for AMD.

Metformin may have a protective effect against AMD

According to review, patients with mild diabetic retinopathy at baseline fare better.

Bariatric surgery may reduce diabetic retinopathy risk

A University of Houston study found that minorities have fewer eye exams, higher instances of disease.

Racial disparities in diabetic eye care

Alimera Sciences, Inc. announces statistically significant improvements in best corrected visual acuity, central subfield thickness and treatment burden for patients with diabetic macular edema.

PALADIN 3-year results: Fluocinolone acetonide intravitreal implant improves visual acuity, CST

Leading the charge for a multifactorial approach to combat diabetes, Kristen Nwanyanwu, MD, MBA, MHS, and her team have embraced the need for a multi-pronged program to address health disparities in diabetic retinopathy.

Conquering the crisis of diabetes among Black Americans

The difference in visual acuities based on CST fluctuations in these patients with diabetic macular edema remained significant.

Fluctuating central subfield thickness in DME may be a predictor of worse VA

Patients’ reluctance to visit a clinic during the COVID-19 pandemic is pushing retina specialists to optimize therapy.

Searching for durable therapies for diabetic macular edema amid the pandemic

Novartis has revealed the first interpretable results from year two (week 100) of the Phase III KESTREL study.

Phase 3 of KESTREL study: Novartis announces positive results for Beovu for treatment of DME

SD-OCT is providing reproducible, high-quality, registered images to assess the treatment response in macular disease.

Managing diabetic eye disease eased with repeatable, high-quality imaging

Speaking at the American Society of Retina Specialists 2021 annual meeting in San Antonio, Rishi P. Singh, MD, provided results of the VISTA and VIVID studies, and he pointed out that the findings could help physicians set expectations of DME therapy. 

Diabetic Eye Awareness